HIGHLIGHTS
Parvovirus B19-associated pure red cell aplasia can recur in the presence of persistent PVB19 viremia in heavily immunosuppressed kidney transplant patients. Recurrent Parvovirus B19-associated pure red cell aplasia should be controlled by reduction of immunosuppression as well as intravenous immunoglobulin therapy.